Stopping Mounjaro without weight regain

There is no withdrawal danger from stopping tirzepatide, the risk is appetite returning faster than your habits can catch it. Here is how we manage that transition.

Hourglass on pebbles

What happens when you stop

Tirzepatide leaves your system over roughly 4 to 5 weeks. Appetite returns gradually, not overnight, and most people describe the "food noise" volume rising week by week. Weight regain is not automatic, but the trial data is plain: without a maintenance plan, most people regain a substantial share of lost weight within a year.

The taper options

Step-down taper (most common)

Drop one dose level every 4 to 8 weeks, say 10 mg to 7.5 mg to 5 mg, then stop. Each step lets you rehearse eating with slightly more appetite while still supported.

Spacing taper

Extend the gap between doses from 7 days to 10, then 14, under prescriber guidance. Off-licence, but useful for people who prefer a gentler slope.

Stopping directly

Safe from a medical standpoint. There is no physical dependence. It simply gives your habits no warm-up. We recommend it only when side effects or circumstances require a quick stop.

A realistic stopping timeline

WeeksPhaseFocus
1 to 4First step downLock in protein target and meal structure while appetite is still muted
5 to 12Continued taperPractise portion habits at rising appetite. Weigh weekly
13 to 16Final doseStrength training routine established. Maintenance calories set
17 onwardOff treatmentMonthly self weigh-ins. Check-in at 3 and 6 months

If the weight starts returning

A 2 to 3 kg uptrend over a month is the trigger to act, not the 10 kg slide. Options include tightening structure, returning to a low maintenance dose for a period, or a short course of extra support. Restarting after a break is straightforward, tell your prescriber how long you have been off, as you may restart at a lower dose to rebuild tolerance.

The mindset shift

Maintenance is not a lesser phase of treatment. It is the treatment, and the medicine was the scaffolding. People who frame it that way keep their results. Our life after GLP-1 guide covers the longer arc.

Continue reading

Mounjaro KwikPen with box

Mounjaro plan from £139 a month

Weekly injection, tirzepatide. Price covers the medicine, prescriber review, monthly check-ins and tracked delivery.

See the Mounjaro plan

Check if treatment suits youFree health check. You pay nothing until a prescriber approves.

Check your eligibility

About this page

Written by
Able Clinic editorial team
Clinical review
Pharmacy team at Curb Healthcare Ltd, GPhC 9012581
Last reviewed

Each page is checked against the UK licence for the medicine. Read our editorial policy.

Sources

  1. NICE TA1026: tirzepatide for managing overweight and obesity
  2. SURMOUNT-1 trial, New England Journal of Medicine 2022
  3. Electronic medicines compendium: Mounjaro product information
  4. MHRA Yellow Card scheme
  5. SURMOUNT-4 trial (tirzepatide withdrawal), JAMA 2024
Check your eligibility